Figure 1: Pharmaceutical Market, Japan, Revenue ($B and ¥B), 2013-2020
Figure 2: Medical Device Market, Japan, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Japan, 2021
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, Japan, 2020
Figure 7: Pharmaceutical Market, Japan, Revenue ($B and ¥B), 2013-2020
Figure 8: Pharmaceutical Market, Japan, Revenue Forecast ($B and ¥B), 2021-2025
Figure 9: AMED Projects, Japan, 2019
Figure 10: Pharmaceutical Exports ($B), Japan, 2013-2020
Figure 11: Top Export Partners, Japan, 2020
Figure 12: Pharmaceutical Imports ($B), Japan, 2013-2020
Figure 13: Top Import Partners, Japan, 2020
Figure 14: Pharmaceutical Supply Channel, Japan, 2021
Figure 15: Generic Drugs Penetration Rate, Japan, 2005-2018
Figure 16: Pharmaceutical, Biotechnology, and Healthcare Clusters, Japan, 2021
Figure 17: OTC Medicines Market, Revenue ($B), Japan, 2013-2020
Figure 18: OTC Medicines Market, Major Distribution Channels ($B), Japan, 2020
Figure 19: OTC Medicines Market, Major Categories ($B), Japan, 2020
Figure 20: Major Therapeutic Areas by Production Value, Japan, 2019
Figure 21: COVID-19 Cases, Japan, 2020-2021
Figure 22: COVID-19 Deaths, Japan, 2020-2021
Figure 23: COVID-19 Fiscal Stimulus Timeline, Japan, 2020-2021
Figure 24: COVID-19 Vaccination Progress, Japan, 2021
Figure 25: COVID-19 Clinical Trials Count by Phase, Japan, 2020-2021
Figure 26: COVID-19 Clinical Trials Count by Trial Status, Japan, 2020-2021
Figure 27: Top Five COVID-19 Clinical Trials Sponsors by Trial Count, Japan, 2020-2021
Figure 28: Medical Devices Market, Japan, Revenue ($B), 2015-2020
Figure 29: Medical Devices Market, Japan, Revenue Forecast ($B), 2021-2025
Figure 30: AMED Projects for Medical Device, Japan, 2020
Figure 31: Medical Device Market, Japan, Major Segments (%), 2020
Figure 32: General Surgery Market, Japan, Revenue ($B), 2017-2025
Figure 33: General Surgery Market, Japan, Market Share of Major Players (%), 2019
Figure 34: Orthopedic Devices Market, Japan, Revenue ($B), 2017-2025
Figure 35: Orthopedic Devices Market, Japan, Market Share of Major Players (%), 2019
Figure 36: Cardiovascular Devices Market, Japan, Revenue ($B), 2017-2025
Figure 37: Cardiovascular Devices Market, Japan, Market Share of Major Players (%), 2019
Figure 38: Wound Care Management Market, Japan, Revenue ($B), 2017-2025
Figure 39: Wound Care Management Market, Japan, Market Share of Major Players (%), 2019
Figure 40: Nephrology and Urology Devices Market, Japan, Revenue ($B), 2017-2025
Figure 41: Nephrology and Urology Devices Market, Japan, Market Share of Major Players (%), 2019
Figure 42: Diagnostics Market, Japan, Revenue ($B), 2015-2020
Figure 43: Diagnostics Market, Japan, Revenue Forecast ($B), 2021-2025
Figure 44: Medical Devices Market, Revenue ($B) of Major Companies, Japan, 2019
Figure 45: Deal Value and Deal Count, Pharmaceutical Market, Japan, 2020-2021
Figure 46: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Japan, 2020-2021
Figure 47: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Japan, 2020-2021
Figure 48: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Japan, 2020-2021
Figure 49: Top Five Therapy Areas by Deal Count, Pharmaceutical Market, Japan, 2020-2021
Figure 50: M&A Deals by Therapy Area, Pharmaceutical Market, Japan, 2020-2021 (by Value ($M) and by Number)
Figure 51: VC Deals by Therapy Area, Pharmaceutical Market, Japan, 2020-2021 (by Value ($M) and by Number)
Figure 52: Medical Devices Market Deals by Deal Value ($M), Japan, 2020-2021
Figure 53: Medical Devices Market Deals by Deal Count, Japan, 2020-2021
Figure 54: Medical Devices Market Deals Share by Deal Value, Japan, 2020-2021
Figure 55: Medical Devices Market Deals Share by Deal Count, Japan, 2020-2021
Figure 56: Top Therapy Area by Deal Value and Deal Count, Medical Devices Market, Japan, 2020-2021
Figure 57: M&A Deals by Therapy Area, Medical Devices Market, Japan, 2020-2021 (by Value ($M) and by Number)
Figure 58: VC Deals by Therapy Area, Medical Devices Market, Japan, 2020-2021 (by Value ($M) and by Number)
Figure 59: PE Deals by Therapy Area, Medical Devices Market, Japan, 2020-2021 (by Value ($M) and by Number)
Figure 60: Development of AI in the Field of Health and Medical Care, Japan, 2019
Figure 61: Deal Value ($M), HealthTech, Japan, 2019-2021
Figure 62: Deal Count (No. of Deals), HealthTech, Japan, 2019-2021
Figure 63: Organization of the Health System, Japan, 2020
Figure 64: Reimbursement Pricing for New Drugs, Japan, 2020
Figure 65: Public Insurance Coverage (% of Population), Japan, 2019
Figure 66: Overview of Medical Service Regime, Japan, 2020
Figure 67: Number of Health Insurance and Cancer Insurance Policies (millions), Japan, 2015-2019
Figure 68: Number of Policies for Hospitalization and Surgery Coverage (millions), Japan, 2014-2019
Figure 69: OOP Expenditure (% of Total Expenditure on Health), Japan, 2013-2020
Figure 70: Reduction in Average Price of Prescription Drugs (%), 2010-2019
Figure 71: New Drug Price Determination Method, Japan, 2020
Figure 72: MHLW, Organization Chart, 2020
Figure 73: Organization of PSEHB and PMDA, Japan, 2020
Figure 74: Drug Approval Process, Japan, 2020
Figure 75: Drug Approval Process Timeline, Japan, 2020
Figure 76: Regenerative Medical Products Approvals, Japan, 2021
Figure 77: Review Pathway of Regenerative Medical Products, Japan, 2021
Figure 78: Patent Approval Process, Japan, 2021
Figure 79: Trademark Approval Process, Japan, 2021
Figure 80: Clinical Trial Notification Process, Japan, 2021
Figure 81: Pharmaceutical Clinical Trials Count by Trial Status, Japan, 2020-2021
Figure 82: Pharmaceutical Clinical Trials Count by Indication, Japan, 2020-2021
Figure 83: Pharmaceutical Clinical Trials Count by Phase, Japan, 2020-2021
Figure 84: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Japan, 2020-2021
Figure 85: Medical Devices Clinical Trials Count by Trial Status, Japan, 2020-2021
Figure 86: Medical Devices Clinical Trials Count by Indication, Japan, 2020-2021
Figure 87: Medical Devices Clinical Trials Count by Category, Japan, 2020-2021
Figure 88: Top Five Medical Devices Clinical Trial Sponsors by Count, Japan, 2020-2021
Figure 89: Drug Manufacturing/Marketing Approvals, Japan, 2021
Figure 90: Medical Device Manufacturing/Marketing Approvals, Japan, 2021
Figure 91: Japan Vision: Health Care 2035, Japan, 2021
Figure 92: Number of Hospitals, Japan, 2012-2018
Figure 93: Number of Diagnostic Equipment, Japan, 2015-2020
Figure 94: Hospital Beds (per 1,000 population), Japan, 2012-2018
Figure 95: Acute Care Hospital Beds (per 1,000 population), Japan, 2012-2018
Figure 96: Psychiatric Care Hospital Beds (per 1,000 population), Japan, 2012-2018
Figure 97: Life Expectancy at Birth (Years), Japan, 2012-2019
Figure 98: Immunization Rate (%), Japan, 2013-2019
Figure 99: PM2.5 (µg per m3), Japan, 2013-2019
Figure 100: CO2 Emissions (Billion Tons), Japan, 2013-2019
Figure 101: Physicians (per 1,000 population), Japan, 2012-2018
Figure 102: Dentists (per 1,000 population), Japan, 2012-2018
Figure 103: Pharmacists (per 1,000 population), Japan, 2012-2018
Figure 104: Nurses (per 1,000 population), Japan, 2012-2018
Figure 105: Major Causes of Mortality (per 100,000 population), Japan, 2019
Figure 106: Major Causes of Male Mortality (per 100,000 population), Japan, 2019
Figure 107: Major Causes of Female Mortality (per 100,000 population), Japan, 2019
Figure 108: Disability-Adjusted Life Years by Major Disease (per 100,000 population), Japan, 2019
Figure 109: Healthcare Expenditure as Percentage of GDP (%), Japan, 2013-2019
Figure 110: Health Expenditure Share (% of total health spending), Japan, 2013-2019
Figure 111: Healthcare Expenditure Components by Function (% of Total Health Expenditure), Japan, 2017
Figure 112: Pharmaceutical Spending (% of total health spending), Japan, 2011-2017